F. Daikhadahmane et al., DISTRIBUTION AND ONTOGENY OF TENASCIN IN NORMAL AND CYSTIC HUMAN FETAL KIDNEYS, Laboratory investigation, 73(4), 1995, pp. 547-557
BACKGROUND: Tenascin is a mesenchymal extracellular matrix glycoprotei
n transiently expressed during development, mainly at the site of epit
helial-mesenchymal interactions. It is thought to play a key role in m
orphogenesis. Little is known about the distribution of tenascin in no
rmal human fetal kidney, and, so far, no data have been reported conce
rning the distribution of the protein in fetal cystic kidneys. EXPERIM
ENTAL DESIGN: Using specific mAb and the immunofluorescence technique,
we analyzed the distribution of tenascin in normal human embryonic (n
= 3), fetal (n = 15), and mature kidneys (n = 4) and in fetuses affec
ted with autosomal recessive polycystic disease (n = 3), autosomal dom
inant polycystic disease (n = 3), and cystic dysplasia (n = 3). We com
pared the distribution of this protein with that of fibronectin and ty
pes I, III, V, and VI, collagens. RESULTS: In normal developing kidney
s, tenascin is present in the uninduced blastema and in the mesenchyme
around differentiating nephrons. It is homogeneously distributed in t
he inner cortex and in the medulla. During maturation, tenascin expres
sion persists in the medulla but progressively decreases in the cortex
. Tenascin is present in the mesangial area from the S-shaped body sta
ge. Both types of polycystic diseases are characterized by a marked an
d diffuse increase in cortical and medullary expression of tenascin as
well as types III, V, and VI collagen. In cystic dysplasia, two types
of changes were observed: (a) increased tenascin and interstitial col
lagen expression in the subcapsular strips of condensed mesenchyme; an
d (b) heterogeneous medullary tenascin distribution with positive labe
ling of the condensed mesenchyme surrounding cysts and primitive ducts
and negative labeling of the loose interstitial mesenchyme, contrasti
ng with the diffuse accumulation of types III, V, and VI collagen. CON
CLUSIONS: In the human fetal kidney, tenascin is expressed by blastema
cells and disappears when converted to epithelium. In polycystic dise
ases, an early increase in tenascin and interstitial collagen expressi
on suggests that renal mesenchyme per se may contribute to the progres
sive alteration of the kidney. In cystic dysplasia, phenotypic changes
in metanephric blastema indicate inappropriate commitment of blastema
cells into interstitial cells, leading to the definitive arrest of ne
phrogenesis; the heterogeneity in tenascin medullary expression underl
ines the heterogeneity in the mesenchymal cell population.